This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Cephalon, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Kim Tran Yap: Innovator in Immunoconjugate Technology
Introduction
Kim Tran Yap is a prominent inventor based in Atherton, CA (US). She has made significant contributions to the field of immunology, particularly through her innovative work on immunoconjugates. Her research focuses on enhancing the efficacy of immunotherapies, which are crucial in the fight against various diseases, including cancer.
Latest Patents
Kim Tran Yap holds a patent for "Anti-pd-1 antibody-attenuated IL-2 immunoconjugates and uses thereof." This patent discloses modified human interleukin-2 (hIL-2) proteins and human antibody molecules that specifically bind to human programmed cell death protein-1 (hPD-1). The immunoconjugates comprising these elements have the potential to improve therapeutic outcomes in patients.
Career Highlights
Throughout her career, Kim has demonstrated a commitment to advancing medical science. She is currently associated with Cephalon, Inc., where she continues to innovate and develop new therapeutic strategies. Her work has garnered attention for its potential to transform treatment protocols in immunotherapy.
Collaborations
Kim has collaborated with notable colleagues, including David S Wilson, Jr. and Paul Ayton. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of her research.
Conclusion
Kim Tran Yap is a trailblazer in the field of immunoconjugate technology, with a focus on improving immunotherapy treatments. Her contributions are paving the way for future advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile